A critical advance in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This crucial tumor protector protein is frequently disabled in various kinds of malignancies, leading https://socialeweb.com/story7449657/vhh-fragments-reactivate-p53-the-promising-hope-for-cancer-therapy